{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:14:27Z","timestamp":1784632467011,"version":"3.55.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1001\/jamaoncol.2018.5911","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T16:33:43Z","timestamp":1546533223000},"page":"689","source":"Crossref","is-referenced-by-count":24,"title":["Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma"],"prefix":"10.1001","volume":"5","author":[{"given":"Sachin R.","family":"Jhawar","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorimar","family":"Rivera-N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick"},{"name":"Biometrics Division, Rutgers Cancer Institute of New Jersey, New Brunswick"},{"name":"Department of Biostatistics, Rutgers School of Public Health, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Drachtman","sequence":"additional","affiliation":[{"name":"Section of Pediatric Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Cole","sequence":"additional","affiliation":[{"name":"Section of Pediatric Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Florida, Gainesville"},{"name":"University of Florida Health Proton Therapy Institute, Jacksonville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul R.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"14","key":"coi180107r1","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1200\/JCO.2002.12.101","article-title":"VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin\u2019s disease: results of a prospective clinical trial.","volume":"20","author":"Donaldson","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi180107r2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","article-title":"Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin\u2019s disease.","volume":"25","author":"Donaldson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"coi180107r3","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.2012.45.3266","article-title":"Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.","volume":"31","author":"D\u00f6rffel","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi180107r4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1200\/JCO.2000.18.7.1500","article-title":"Localized childhood Hodgkin\u2019s disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy\u2014results of the French Society of Pediatric Oncology Study MDH90.","volume":"18","author":"Landman-Parker","year":"2000","journal-title":"J Clin Oncol"},{"issue":"23","key":"coi180107r5","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","article-title":"Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin\u2019s lymphoma: the GPOH-HD-2002 study.","volume":"28","author":"Mauz-K\u00f6rholz","year":"2010","journal-title":"J Clin Oncol"},{"issue":"24","key":"coi180107r6","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1001\/jama.2012.5847","article-title":"Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.","volume":"307","author":"Metzger","year":"2012","journal-title":"JAMA"},{"issue":"18","key":"coi180107r7","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1200\/JCO.2002.12.007","article-title":"Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin\u2019s disease who achieve a complete response to chemotherapy.","volume":"20","author":"Nachman","year":"2002","journal-title":"J Clin Oncol"},{"issue":"12","key":"coi180107r8","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1200\/JCO.1999.17.12.3736","article-title":"High cure rates and reduced long-term toxicity in pediatric Hodgkin\u2019s disease: the German-Austrian multicenter trial DAL-HD-90.","volume":"17","author":"Schellong","year":"1999","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi180107r9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/pbc.v59.7","article-title":"Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children\u2019s Oncology Group.","volume":"59","author":"Tebbi","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"26","key":"coi180107r10","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1200\/JCO.2011.41.1819","article-title":"Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin\u2019s lymphoma\u2014a report from the Children\u2019s Oncology Group.","volume":"30","author":"Wolden","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi180107r11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1053-4296(96)80018-X","article-title":"Long-term complications of treatment and causes of mortality after Hodgkin\u2019s disease.","volume":"6","author":"Hancock","year":"1996","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"coi180107r12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1200\/JCO.2012.44.5791","article-title":"Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.","volume":"31","author":"Koontz","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"coi180107r13","first-page":"3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin\u2019s disease: data from the Childhood Cancer Survivor Study.","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"coi180107r14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5581\/1516-8484.20120014","article-title":"Fertility in female survivors of Hodgkin\u2019s lymphoma.","volume":"34","author":"Biasoli","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"32","key":"coi180107r15","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1200\/JCO.2009.22.8312","article-title":"Fertility preservation in adolescents and young adults with cancer.","volume":"28","author":"Levine","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"coi180107r16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/bjh.2015.169.issue-5","article-title":"Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.","volume":"169","author":"Giulino-Roth","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"coi180107r17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/10428194.2011.608455","article-title":"The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.","volume":"53","author":"Hawkes","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"coi180107r18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bjh.2015.171.issue-2","article-title":"Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma\u2014a review of clinical outcome based on the histological variants.","volume":"171","author":"Shankar","year":"2015","journal-title":"Br J Haematol"},{"issue":"16","key":"coi180107r19","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response\u2013adapted treatment in stage I and II Hodgkin lymphoma: final results of the Randomized EORTC\/LYSA\/FIL H10 Trial.","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi180107r20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijrobp.2015.06.039","article-title":"Early-stage classic Hodgkin lymphoma: the utilization of radiation therapy and its impact on overall survival.","volume":"93","author":"Parikh","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi180107r21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"coi180107r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(ISSN)1096-9098","article-title":"The National Cancer Data Base: a clinical surveillance and quality improvement tool.","volume":"85","author":"Winchester","year":"2004","journal-title":"J Surg Oncol"},{"issue":"15","key":"coi180107r23","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1002\/cncr.31519","article-title":"Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: a report from the Children\u2019s Oncology Group.","volume":"124","author":"Keller","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"coi180107r24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3324\/haematol.2009.015644","article-title":"Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin\u2019s lymphoma: a systematic review.","volume":"95","author":"Herbst","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"coi180107r25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ijrobp.2010.10.069","article-title":"Declining use of radiotherapy in stage I and II Hodgkin\u2019s disease and its effect on survival and secondary malignancies.","volume":"82","author":"Koshy","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"coi180107r26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1200\/JCO.2014.58.7543","article-title":"Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.","volume":"33","author":"Olszewski","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"coi180107r27","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3109\/10428194.2010.525724","article-title":"Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005: an analysis of 21 734 cases.","volume":"51","author":"Bazzeh","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"coi180107r28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/pbc.v63.3","article-title":"Racial and ethnic disparities in the pediatric Hodgkin lymphoma population.","volume":"63","author":"Grubb","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"coi180107r29","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3109\/10428194.2013.798868","article-title":"Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant.","volume":"54","author":"Arai","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"32","key":"coi180107r30","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children\u2019s Oncology Group Study AHOD0031.","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"15","key":"coi180107r31","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer.","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"coi180107r32","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"issue":"2","key":"coi180107r33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.prro.2014.05.003","article-title":"Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: guidelines from the International Lymphoma Radiation Oncology Group.","volume":"5","author":"Hodgson","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"coi180107r34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijrobp.2016.01.053","article-title":"A comparative evaluation of normal tissue doses for patients receiving radiation therapy for Hodgkin lymphoma on the Childhood Cancer Survivor Study and Recent Children\u2019s Oncology Group trials.","volume":"95","author":"Zhou","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi180107r35","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","article-title":"Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin\u2019s lymphoma.","volume":"82","author":"Paumier","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi180107r36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ijrobp.2017.05.004","article-title":"Evidence-based review on the use of proton therapy in lymphoma from the Particle Therapy Cooperative Group (PTCOG) lymphoma subcommittee.","volume":"99","author":"Tseng","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"coi180107r37","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/pbc.v63.9","article-title":"Proton therapy for pediatric Hodgkin lymphoma.","volume":"63","author":"Wray","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"coi180107r38","doi-asserted-by":"publisher","first-page":"e26278","DOI":"10.1002\/pbc.26278","article-title":"Childhood Hodgkin International Prognostic Score (CHIPS) predicts event-free survival in Hodgkin lymphoma: a report from the Children\u2019s Oncology Group.","volume":"64","author":"Schwartz","year":"2017","journal-title":"Pediatr Blood Cancer"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/5\/689\/17575109\/jamaoncology_jhawar_2019_oi_180107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T16:59:05Z","timestamp":1557421145000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.5911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.5911","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}